West Pharmaceutical Services WST Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's operating margin?
- West Pharmaceutical Services (WST) reported operating margin of 20.3% in Q1 2026.
- How has West Pharmaceutical Services's operating margin changed year-over-year?
- West Pharmaceutical Services's operating margin increased by 6.3% year-over-year, from 19.1% to 20.3%.
- What is the long-term trend for West Pharmaceutical Services's operating margin?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's operating margin has grown at a -5.6% compound annual growth rate (CAGR), from 97.2% to 77.3%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.